CYMBALTA is in a class of drugs known to affect urethral resistance. Urinary hesitation and retention have been observed in clinical trials for
Urinary Hesitation And Retention. CYMBALTA is in a class of drugs known to affect urethral resistance. If symptoms of urinary hesitation develop during treatment with CYMBALTA, consideration should be given to the possibility that they might be drug-related. In post marketing experience, cases of urinary retention have been observed.
HbA1c increased by 0.5% in the Cymbalta and by 0.2% in the routine care groups. 5.13 Urinary Hesitation and Retention. Cymbalta is in a class of drugs known to
5.15 Urinary Hesitation and Retention CYMBALTA is in a class of drugs known to affect urethral resistance. If symptoms of urinary hesitation develop during treatment with CYMBALTA, consideration should be given to the possibility that they might be drug-related. In post marketing experience, cases of urinary retention have been observed.
Urinary retention; Stomach pain; Confusion; Memory impairment; Irregular Cymbalta (duloxetine). Cymbalta is a serotonin and
There is a less than 1% reported incidence of urinary frequency/retention with Cymbalta. The incidence with Savella is over 2%, which is a
What is urinary retention? Urinary retention is the inability to . empty the bladder completely. Urinary retention can be acute or chronic. Acute urinary retention happens suddenly and lasts only a short time. People with acute urinary retention cannot urinate at all, even though they have a full bladder. Acute urinary retention, a potentially
HbA1c increased by 0.5% in the Cymbalta and by 0.2% in the routine care groups. 5.13 Urinary Hesitation and Retention. Cymbalta is in a class of drugs known to
HbA1c increased by 0.5% in the CYMBALTA group and by 0.2% in the routine care group. 5.15 Urinary Hesitation and Retention. CYMBALTA is in a class of drugs
Comments